Transaction #1859 · Form 4 · 0001213900-25-100720
InMed Pharmaceuticals Inc. · Stock award · Employee Stock Option (Right to Buy)
InMed Pharmaceuticals Inc. · Transacted October 17, 2025 · Filed October 21, 2025
What does this filing report?
An SEC Form 4 filing for InMed Pharmaceuticals Inc. records a stock award involving Employee Stock Option (Right to Buy) on October 17, 2025. The reported quantity was 3,500. The filing date is October 21, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- InMed Pharmaceuticals Inc.
- Company CIK
- 0001728328
- Security type
- Derivative
- Acquisition type
- Stock award · Code A
- Quantity acquired
- 3,500
- Reported price
- 0
- Reference value
- 0
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 3,500
- Ownership description
- Not reported
- SEC acceptance time
- Oct 21, 2025, 1:58 PM EDT
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Klompas Neil A ↗
Director
CIK 0001761857
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
This transaction is not mapped to a specific company listing.
Derivative terms
- Underlying security
- Common shares
- Underlying quantity
- 3,500
- Conversion / exercise price
- 2.1
- Exercise date
- Not reported
- Expiration date
- October 16, 2030
Filing footnotes & remarks
- F1
- (1) The options were granted on Oct 17, 2025 and will vest monthly, in arrears, as follows: (i) 98 stock options will vest on the 17th day of each month for 35 months, and (ii) 70 stock options will vest on Oct 17, 2025 (the three year anniversary of Grant date).
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.